NFSG
SAGE icon

Newbridge Financial Services Group’s Sage Therapeutics SAGE Stock Holding History

Newbridge Financial Services Group’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-22
Closed -$453 – 1304
2023
Q3 		$453 Hold
22
– – ﹤0.01% 1209
2023
Q2 		$1.03K Hold
22
– – ﹤0.01% 1213
2023
Q1 		$923 Hold
22
– – ﹤0.01% 1282
2022
Q4 		$839 Hold
22
– – ﹤0.01% 1316
2022
Q3 		$1K Hold
22
– – ﹤0.01% 1332
2022
Q2 		$1K Hold
22
– – ﹤0.01% 1305
2022
Q1 		$1K Hold
22
– – ﹤0.01% 1399
2021
Q4 		$1K Hold
22
– – ﹤0.01% 1356
2021
Q3 		$1K Hold
22
– – ﹤0.01% 1306
2021
Q2 		$1K Hold
22
– – ﹤0.01% 1388
2021
Q1 		$2K Buy
+22
New +$1.8K ﹤0.01% 1194

Other funds holding SAGE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Newbridge Financial Services Group's SAGE Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of Sage Therapeutics (SAGE) in Q4 2023, closing a stake of 22 shares — an estimated $453 sold.

Newbridge Financial Services Group first reported a position in SAGE in Q1 2021 and held it in 11 quarters. The position peaked at $2K in Q1 2021. 201 funds tracked by Wall St. Rank hold SAGE as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining Sage Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 22 Sage Therapeutics shares in Q4 2023, an estimated $453.
  • Newbridge Financial Services Group first reported a position in Sage Therapeutics in Q1 2021 and held it in 11 quarters.
  • Newbridge Financial Services Group's Sage Therapeutics position peaked at $2K in Q1 2021.
  • 201 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.